Welcome to CrownBio’s Blog where we share our thoughts
on the latest trends and hot stories in Oncology and CVMD

July 28, 2015 New Novartis Drug Resolves the Thorny Issue of Hedgehog Activation in Locally Advanced Basal Cell Carcinoma Skin cancer is the most common type of cancer. It is estimated that about 80% of non-melanoma skin cancers are of the basal cell carcinoma subtype. The FDA has recently approved Novartis Odomzo® (sonidegib) for the treatment of locally advanced basal cell carcinoma for adult patients who are not candidates for surgery or radiation therapy or whose disease ... LEARN MORE
July 21, 2015 The Common Cold Virus Will Help Us Sneezing Out Cancer Viruses are small agents that only replicate inside living cells of the organism they infect. Some of them, called ... LEARN MORE
July 14, 2015 Got Type 2 Diabetes? You May Blame Your Ancestors' Diet A wealth of studies supports the notions that a high-fat-diet causes obesity and that developing type 2 diabetes is one ... LEARN MORE
July 7, 2015 Have We Finally Isolated A Pancreatic Cancer Biomarker? Unlike some other cancer forms death rates from pancreatic cancer have been continuously raising due to a persistent ... LEARN MORE